Nouvelle déclaration d'incident
No de la demande: 2016-1378
Numéro de référence du titulaire d'homologation: 1735307
Nom du titulaire (nom légal complet, aucune abbréviation): Bell Laboratories, Inc.
Adresse: 3699 Kinsman Blvd
Ville: Madison
État: WI
Pays: USA
Code postal /Zip: 53704
Incident chez l'humain
Pays: CANADA
État: NOVA SCOTIA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Contrac (non-specific)
Oui
Inconnu
Site: Res. - In Home / Rés. - à l'int. maison
Inconnu
Personne affectée
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Inconnu
Non
Inconnu
Non professionnel
Quelle était l'activité? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Autre
Aucun
Inconnu
>1 wk <=1 mo / > 1 sem < = 1 mois
>1 wk <=1 mo / > 1 sem < = 1 mois
12/10/2015 The caller states that the her apartment management put the products in the floor joists of her apartment 3-4 weeks prior to the call. Approximately 24-36 hours prior to the call she began to experience symptoms of muscle cramps, headache, nausea, and tinging in the hands. The symptoms wax and wane but seem to begin about 30 minutes after being in her home but she could not determine how long it took for her symptoms to resolve once she left the home. Her husband also is experiencing symptoms of muscle cramps, tingling in the hands and dizziness although she does not know when his symptoms started or if they correlate to being in the home. The caller denies any direct exposure to the product but is concerned she may be inhaling it. The caller was advised that the product dose not release pesticide into the air and that the reported symptoms do not correlate with exposure. Advised her and her husband to consult their physician.
Mineure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.
Personne affectée
Sexe: Homme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Inconnu
Non
Inconnu
Non professionnel
Quelle était l'activité? Please refer to field 13 on Subform II or field 17 of subform III for a detailed description regarding the activity
Autre
Aucun
Inconnu
>1 wk <=1 mo / > 1 sem < = 1 mois
>1 wk <=1 mo / > 1 sem < = 1 mois
12/10/2015 The caller states that the her apartment management put the products in the floor joists of her apartment 3-4 weeks prior to the call. Approximately 24-36 hours prior to the call she began to experience symptoms of muscle cramps, headache, nausea, and tinging in the hands. The symptoms wax and wane but seem to begin about 30 minutes after being in her home but she could not determine how long it took for her symptoms to resolve once she left the home. Her husband also is experiencing symptoms of muscle cramps, tingling in the hands and dizziness although she does not know when his symptoms started or if they correlate to being in the home. The caller denies any direct exposure to the product but is concerned she may be inhaling it. The caller was advised that the product dose not release pesticide into the air and that the reported symptoms do not correlate with exposure. Advised her and her husband to consult their physician.
Mineure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.